Author's Reply

Value Health. 2021 Jul;24(7):1086-1087. doi: 10.1016/j.jval.2020.12.025. Epub 2021 Apr 20.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cost-Benefit Analysis*
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Protein Kinase Inhibitors / economics*
  • Protein Kinase Inhibitors / therapeutic use*

Substances

  • Protein Kinase Inhibitors